Diagnosis and Treatment of Blood Disorders and Blood Cancers

Published:  ·  Last Updated:  ·  Prepared by the Academic Hospital Web and Editorial Board.

Hematology is the subspecialty of internal medicine covering the diagnosis and treatment of benign and malignant diseases that affect the blood cells (red cells, white cells and platelets) and the coagulation system. The department provides care across a wide clinical spectrum, from the various types of anaemia to leukaemia and lymphoma, and from coagulation disorders to bone marrow diseases. While applying chemotherapy, targeted therapy and immunotherapy protocols, the Academic Hospital Hematology Department works in coordination with the Bone Marrow Transplantation unit where required.

Academic Hospital Hematology Department

What Is Hematology?

Hematology is the medical specialty that studies, diagnoses and treats diseases of the blood and the blood-forming organs, including the bone marrow in which blood is produced. Hematology specialists work across a broad area of clinical responsibility, from interpreting the full blood count to performing bone marrow biopsies, and from administering intravenous chemotherapy to long-term disease management. The department focuses on both benign conditions (anaemia, thrombocytopenia, coagulation disorders) and malignant ones (leukaemia, lymphoma, myeloma).

Which Diseases and Conditions Are Treated?

The hematology department covers a broad group of diseases affecting the blood and the bone marrow.

Anaemias

  • Iron deficiency anaemia
  • Megaloblastic anaemia due to vitamin B12 and folic acid deficiency
  • Haemolytic anaemias (autoimmune, hereditary spherocytosis, G6PD deficiency)
  • Aplastic anaemia (bone marrow failure)
  • Sickle cell anaemia and thalassaemia

Blood Cancers

  • Acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL)
  • Chronic myeloid leukaemia (CML) and chronic lymphocytic leukaemia (CLL)
  • Hodgkin lymphoma and non-Hodgkin lymphoma
  • Multiple myeloma and plasma cell disorders
  • Myelodysplastic syndrome (MDS) and myeloproliferative neoplasms

Coagulation and Bleeding Disorders

  • Immune thrombocytopenic purpura (ITP)
  • Haemophilia A and B
  • Von Willebrand disease
  • Deep vein thrombosis (DVT) and pulmonary embolism
  • Inherited thrombophilias (factor V Leiden, protein C/S deficiency)

When Should You Consult a Specialist?

The following symptoms may point to a haematological problem and require specialist assessment.

  • Persistent tiredness, weakness and a pale complexion
  • Unexplained enlargement of the lymph nodes in the neck, armpit or groin
  • Bruising under the skin, pinpoint red spots (petechiae) or bleeding that is slow to stop
  • Night sweats, fever and unexplained weight loss
  • Rapid palpitations and shortness of breath together with marked pallor
  • Nosebleeds that do not stop for a long time, or excessive bleeding after a tooth extraction
  • Unexpected anaemia, leucocytosis (a high white cell count) or a low platelet count on a blood test
  • Joint swelling and pain accompanied by a bleeding tendency (suspected haemophilia)

Situations requiring emergency care: Go to the emergency department immediately in case of high fever with a severely low white cell count (neutropenia), signs of major internal bleeding, sudden shortness of breath together with a low platelet count, or complications of severe anaemia.

Diagnostic Methods

In the hematology department the diagnosis is established through blood analyses, bone marrow examination and molecular tests.

Method What it is used for
Assessment of the number and morphology of red cells, white cells and platelets; the first step in the diagnosis of leukaemia and anaemia.
Microscopic examination of bone marrow samples taken from the iliac bone with a fine needle; essential in the diagnosis of leukaemia, lymphoma, myeloma and aplastic anaemia.
Detection of abnormal cell types in blood or bone marrow samples by immunophenotyping; used to determine the subtypes of leukaemia and lymphoma.
Detection, by chromosome analysis (karyotyping), FISH and PCR, of the genetic changes that determine the type and prognosis of a leukaemia (such as BCR-ABL, FLT3 and NPM1).
Diagnosis of haemophilia and thrombophilia using PT, aPTT, fibrinogen, D-dimer and factor levels.
Detection of the abnormal protein (M protein) in multiple myeloma.
Assessment of disease extent and treatment response in lymphoma and leukaemia.
Detection, by next-generation sequencing, of the mutations that influence the treatment decision.

Treatment Approaches

In the hematology department, treatment protocols are individualised according to the type and stage of the disease and the patient's general condition.

Treatment Scope and application
Intravenous or oral drug combinations in the treatment of leukaemia, lymphoma and myeloma; the type of protocol is determined by the diagnosis and the genetic profile.
Tyrosine kinase inhibitors such as imatinib and dasatinib in CML; FLT3 or IDH inhibitors in AML. These drugs act on a specific molecular target and therefore cause less damage to healthy cells.
Rituximab and obinutuzumab in lymphoma and CLL; daratumumab in myeloma; bispecific antibodies such as blinatumomab in certain leukaemias.
Applied as supportive treatment in severe anaemia and in low platelet counts.
Low molecular weight heparin or direct oral anticoagulants (DOACs) for the treatment and prophylaxis of thrombosis (blood clots).
Ciclosporin, corticosteroid and antithymocyte globulin (ATG) treatments in aplastic anaemia and autoimmune haemolytic anaemia.
Oral or intravenous iron in iron deficiency anaemia; vitamin support in B12 and folic acid deficiency.
Transplant planning in high-risk leukaemia, lymphoma and aplastic anaemia, carried out together with the Bone Marrow Transplantation unit.

Book an appointment with the Hematology Department.

Book an Appointment

Hematology at Academic Hospital

The Academic Hospital Hematology Department carries out outpatient assessment, day-case chemotherapy and inpatient follow-up under one roof; bone marrow aspiration and biopsy procedures are performed within the hospital. The department works routinely with the following units:

  • Medical Oncology: joint management of cases involving both lymphoma and solid tumours
  • Pathology: histopathological assessment of bone marrow and lymph node biopsies
  • Internal Medicine: initial assessment, anaemia screening and referral
  • Biochemistry: processing of full blood count, coagulation and protein electrophoresis tests
  • Infectious Diseases: management of neutropenic fever and treatment-related infections
  • Radiology: staging and treatment response assessment with PET-CT and computed tomography
  • Gynecology and Obstetrics: joint follow-up of anaemia and coagulation disorders in pregnancy

Frequently Asked Questions

Is a bone marrow biopsy painful?
A bone marrow biopsy is performed under local anaesthesia; the area is numbed during the procedure. A brief sensation of pressure and mild tension may be felt, but the pain is generally at a tolerable level. The procedure takes 10-15 minutes and mild tenderness may follow for a few days. Additional sedation can be given to anxious patients.
How long does treatment last after a diagnosis of leukaemia?
The duration of treatment varies considerably according to the type and stage of the leukaemia. In acute leukaemias, intensive induction chemotherapy is given in hospital at the start, after which maintenance treatment may last from months to years. In chronic leukaemias, targeted therapies are mostly delivered over the long term with oral medication. The treatment plan is updated according to the individual genetic profile and the response.
What is the difference between lymphoma and leukaemia?
Leukaemia is a blood cancer that affects the bone marrow and blood cells, with abnormal cells circulating in the blood. Lymphoma originates in the lymph nodes and the lymphatic system and is examined in two main groups, Hodgkin and non-Hodgkin. Although both diseases are managed by the hematology department, their diagnostic, staging and treatment protocols differ.
Is ITP (immune thrombocytopenic purpura) a dangerous disease?
ITP is an autoimmune condition in which the body mistakenly suppresses its own production of platelets (the cells responsible for clotting). It requires close follow-up because of the risk of serious bleeding, but in most cases it can be brought under control with corticosteroids and immunotherapy. When the platelet count is very low or there is active bleeding, urgent treatment is given.
Can a patient with haemophilia have surgery?
Yes, patients with haemophilia can undergo surgery safely when appropriate factor replacement (administration of the missing clotting factor beforehand) is provided. This process requires joint planning by the hematology specialist and the anaesthesia and surgical teams. At Academic Hospital, a preoperative hematology consultation is part of the standard protocol.

Appointment and Information

444 0 353

Weekdays 08:00-18:00

References

The general information given on this page about blood disorders, diagnostic methods and treatment approaches is supported by the reliable health sources listed below.

  1. American Society of Hematology (ASH), "Hematology Guidelines", hematology.org
  2. European Hematology Association (EHA), "EHA Clinical Practice Guidelines", ehaweb.org
  3. National Cancer Institute (NIH), "Hematologic Cancers", cancer.gov

The information on this page is for informational purposes only; it does not replace medical examination, diagnosis or treatment. Please consult a healthcare institution regarding your complaints.

Thank you!

Your request has been received.
You will be contacted as soon as possible.

OK

Error!

An error occurred.
Please try submitting the form again after a while.

OK